Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid
Authors:
- Paul E. KeckPKPaul E. Keck
- Nosa N. EkhatorNENosa N. Ekhator
- Scott A. WestSWScott A. West
- Dewleen G. BakerDBDewleen G. Baker
- Kelly K. HillKHKelly K. Hill
- Ann B. BruceABAnn B. Bruce
- Matthew D. WortmanMWMatthew D. Wortman
- 1 August 1998
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 44 (3) , 228-233
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Sertraline and GalactorrheaJournal of Clinical Psychopharmacology, 1996
- Serotonin-dopamine interaction and its relevance to schizophreniaAmerican Journal of Psychiatry, 1996
- Intercellular communication in the brain: Wiring versus volume transmissionNeuroscience, 1995
- Extrapyramidal Symptoms with Selective Serotonin Reuptake InhibitorsThe British Journal of Psychiatry, 1994
- Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholismBrain Research, 1993
- Clinical investigation of monoamine neurotransmitter interactionsPsychopharmacology, 1993
- The effects of gepirone on neuroendocrine function and temperature in humansPsychopharmacology, 1990
- Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonistBiological Psychiatry, 1988
- Interacting neurotransmitter systems. A non-experimental approach to the 5hiaa-hva correlation in human CSFJournal of Psychiatric Research, 1986
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968